Literature DB >> 21189322

Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.

Joseph T Agnes1, Kelly A Brayton, Megan LaFollett, Junzo Norimine, Wendy C Brown, Guy H Palmer.   

Abstract

Live vaccination with Anaplasma marginale subsp. centrale (synonym for Anaplasma centrale) induces protection against severe disease upon challenge with A. marginale sensu stricto strains. Despite over a century of field use, the targets of protective immunity remained unknown. Using a broad proteomic approach, we identified the proteins in a challenge sensu stricto strain that were bound by the relevant antibody isotype induced by live vaccination with Anaplasma marginale subsp. centrale. A core of 15 proteins was identified in vaccinated animals across multiple major histocompatibility complex (MHC) haplotypes. This core separated into two structural/functional classes: "housekeeping" proteins involved in replication and metabolism and outer membrane proteins (OMPs). Orthologous proteins of both classes were identified within the vaccine strain and among sensu stricto strains. In contrast to the broad conservation among strains in the sequences of the housekeeping proteins, there was significantly greater divergence in the OMPs and greater divergence in both OMP sequences and the encoding locus structure between the vaccine strain and the sensu stricto strains than among the sensu stricto strains. The OMPs bound by live vaccine-induced antibody overlapped with OMPs that were immunogenic in animals vaccinated with inactivated vaccines and subsequently protected against bacteremia and disease. The identification of this core set of OMPs is consistent with the hypothesis that "subdominant" immunogens are required for vaccine-induced protection against A. marginale and provides clear direction for development of a safer, more effective vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189322      PMCID: PMC3067503          DOI: 10.1128/IAI.01174-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale.

Authors:  G H Palmer; F R Rurangirwa; K M Kocan; W C Brown
Journal:  Parasitol Today       Date:  1999-07

Review 2.  Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale.

Authors:  G H Palmer; W C Brown; F R Rurangirwa
Journal:  Microbes Infect       Date:  2000-02       Impact factor: 2.700

3.  Complete genome sequence of Anaplasma marginale subsp. centrale.

Authors:  David R Herndon; Guy H Palmer; Varda Shkap; Donald P Knowles; Kelly A Brayton
Journal:  J Bacteriol       Date:  2010-01       Impact factor: 3.490

4.  Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia.

Authors:  D M French; W C Brown; G H Palmer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.

Authors:  W C Brown; T C McGuire; D Zhu; H A Lewin; J Sosnow; G H Palmer
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics.

Authors:  A F Barbet; A Lundgren; J Yi; F R Rurangirwa; G H Palmer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Sir Arnold Theiler and the discovery of anaplasmosis: a centennial perspective.

Authors:  G H Palmer
Journal:  Onderstepoort J Vet Res       Date:  2009-03       Impact factor: 1.792

8.  Independence of Anaplasma marginale strains with high and low transmission efficiencies in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host.

Authors:  Maria F B M Galletti; Massaro W Ueti; Donald P Knowles; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

9.  Generation of antigenic variants via gene conversion: Evidence for recombination fitness selection at the locus level in Anaplasma marginale.

Authors:  James E Futse; Kelly A Brayton; Seth D Nydam; Guy H Palmer
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

10.  Conservation in the face of diversity: multistrain analysis of an intracellular bacterium.

Authors:  Michael J Dark; David R Herndon; Lowell S Kappmeyer; Mikel P Gonzales; Elizabeth Nordeen; Guy H Palmer; Donald P Knowles; Kelly A Brayton
Journal:  BMC Genomics       Date:  2009-01-11       Impact factor: 3.969

View more
  16 in total

1.  Genome-wide screening and identification of antigens for rickettsial vaccine development.

Authors:  Guy H Palmer; Wendy C Brown; Susan M Noh; Kelly A Brayton
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02

2.  Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Authors:  Pablo A Nuñez; Rosalia Moretta; Paula Ruybal; Silvina Wilkowsky; Marisa D Farber
Journal:  Curr Microbiol       Date:  2013-10-15       Impact factor: 2.188

3.  Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.

Authors:  James R Deringer; Elkin G Forero-Becerra; Massaro W Ueti; Joshua E Turse; James E Futse; Susan M Noh; Guy H Palmer; Wendy C Brown
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

4.  Reduced Infectivity in cattle for an outer membrane protein mutant of Anaplasma marginale.

Authors:  Francy L Crosby; Kelly A Brayton; Forgivemore Magunda; Ulrike G Munderloh; Karen L Kelley; Anthony F Barbet
Journal:  Appl Environ Microbiol       Date:  2015-01-16       Impact factor: 4.792

5.  Primary Structural Variation in Anaplasma marginale Msp2 Efficiently Generates Immune Escape Variants.

Authors:  Telmo Graça; Lydia Paradiso; Shira L Broschat; Susan M Noh; Guy H Palmer
Journal:  Infect Immun       Date:  2015-08-10       Impact factor: 3.441

6.  Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.

Authors:  G Kenitra Hammac; Pei-Shin Ku; Maria F Galletti; Susan M Noh; Glen A Scoles; Guy H Palmer; Kelly A Brayton
Journal:  Vaccine       Date:  2013-05-09       Impact factor: 3.641

7.  Expansion of variant diversity associated with a high prevalence of pathogen strain superinfection under conditions of natural transmission.

Authors:  Massaro W Ueti; Yunbing Tan; Shira L Broschat; Elizabeth J Castañeda Ortiz; Minerva Camacho-Nuez; Juan J Mosqueda; Glen A Scoles; Matthew Grimes; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

8.  Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.

Authors:  Saleh M Albarrak; Wendy C Brown; Susan M Noh; Kathryn E Reif; Glen A Scoles; Joshua E Turse; Junzo Norimine; Massaro W Ueti; Guy H Palmer
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.

Authors:  Michael J Dark; Basima Al-Khedery; Anthony F Barbet
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

10.  Lambs immunized with an inactivated variant of Anaplasma phagocytophilum.

Authors:  Snorre Stuen; Wenche Okstad; Karin Artursson; Basima Al-Khedery; Anthony Barbet; Erik G Granquist
Journal:  Acta Vet Scand       Date:  2015-07-25       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.